Appia Pharmaceuticals
Manufacturing · Connecticut, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14 Paddock Dr, Greenwich, Connecticut, 0...Website
www.appiapharma.comRevenue
$10.7 MillionIndustry
About Appia Pharmaceuticals
Appia Pharmaceutical is a clinical stage drug development company founded in 2014, focused on modulating gene transcription factors to develop innovative drugs. The company utilizes a lean biotech model, leveraging academic collaborations and certified contract organizations. With a robust portfolio of patents, Appia's research targets conditions ranging from cancer to neurodegeneration. Their proprietary compounds aim to reverse abnormal epigenetic modifications in affected cells.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAppia Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Appia Pharmaceuticals
Compare insights from companies similar to Appia Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Appia Pharmaceuticals Tech Stack
A closer look at the technologies used by Appia Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Appia Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Appia Pharmaceutical is a clinical stage drug development company founded in 2014, focused on modulating gene transcription factors to develop innovative drugs. The company utilizes a lean biotech model, leveraging academic collaborations and certified contract organizations. With a robust portfolio of patents, Appia's research targets conditions r... Read More
